HSP90AA1 and COVID-19: Treatment with the Hsp90 inhibitor 17-DMAG significantly reduced gross and microscopic lesions in the lungs of infected hamsters, though some evidence of toxicity indicates the potential limitations of Hsp90 inhibitors for treatment of COVID-19.